JENNIFER POE: Open Payments
NPI 1073157426 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 13 payments from 8 companies in 2025. Trend: 2023 $230 · 2024 $26 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $103 |
| Exact Sciences Corporation | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $15 |
| TMS NeuroHealth Centers Inc. | 1 | $14 |
Products named: ELIQUIS, PREVNAR 20, TRELEGY ELLIPTA, Kerendia, GEMTESA, EVENITY, Cologuard Collection Kit, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
